Stryker wins FDA 510(k) for MultiGen 2 RF generator

Stryker (NYSE:SYK) said today it won FDA 510(k) clearance for its MultiGen 2 radiofrequency energy generator designed for RF ablation procedures.

The newly cleared MultiGen 2 generator is designed with double the industry standard for power to achieve its target temperature faster with fewer errors and increased reliability and efficiency, the Kalamazoo, Mich.-based company said.

“The next generation of radiofrequency ablation has arrived. The MultiGen 2 RF Generator provides physicians with control and confidence, making radiofrequency ablation more efficient and reliable than ever before,” brand manager Brad Wallace said in a prepared statement.

The device allows physicians to physicians to create strip lesions without removing electrodes, resolve errors without stopping procedures and can be activated with a single button push, Stryker said.

Last month, Stryker said it agreed to pay $700 million to acquire Novadaq Technologies (TSE:NVDQ) and its line of fluorescence imaging technology.

The post Stryker wins FDA 510(k) for MultiGen 2 RF generator appeared first on MassDevice.

from MassDevice http://ift.tt/2sMduTj